CEVR analyzes the value of strategies to improve health and health care.

About Us

Recent Publications

Health Affairs Forefront
Lessons From TAVR For Medicare’s ‘Coverage With Evidence Development’ Program
View publication
June 11, 2026
Learning Health Systems
Effect of Using Personalized Estimates of Diabetes Risk During Primary Care Visits for People With Prediabetes
View publication
May 27, 2026
JCO Oncology Practice
Trends in Utilization Management for Oncology Therapies Amongst US Commercial Health Plans: 2017-2024
View publication
May 21, 2026
Health Affairs Scholar
Cost-Effectiveness Thresholds Used in the United States versus Most Favored Nations
View publication
April 3, 2026
Health Affairs Scholar
The timeliness of health plan drug coverage policy changes to FDA label revisions
View publication
February 13, 2026
Health Affairs Scholar
FDA approvals of specialty drugs, 2000-2024
View publication
February 7, 2026
JAMA Network Open
Drug Prices, Rebates, and Health Plan Coverage Restrictions
View publication
February 6, 2026
JMCP
Use of Clinical Outcome Assessments in Specialty Drug Coverage Policies
View publication
February 4, 2026

The CEVR Team

Our team of experienced, dedicated researchers is led by health economists Peter Neumann and Josh Cohen. Together we produce cutting-edge health care cost-effectiveness research.

Meet the CEVR Team

Our Databases

Our comprehensive databases provide the information individuals and organizations need to analyze the benefits, risks, and costs of strategies to improve health and health care.